Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 421

1.

Transient amplifiers of selection and reducers of fixation for death-Birth updating on graphs.

Allen B, Sample C, Jencks R, Withers J, Steinhagen P, Brizuela L, Kolodny J, Parke D, Lippner G, Dementieva YA.

PLoS Comput Biol. 2020 Jan 17;16(1):e1007529. doi: 10.1371/journal.pcbi.1007529. eCollection 2020 Jan.

2.

A cross-sectional survey on medical education needs of general practitioners and family medicine: Delhi, Himachal Pradesh and Tamil Nadu, India.

Bakshi S, Kaljee L, Parke D.

J Family Med Prim Care. 2019 Nov 15;8(11):3531-3537. doi: 10.4103/jfmpc.jfmpc_644_19. eCollection 2019 Nov.

3.

An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance.

Deng S, Krutilina RI, Wang Q, Lin Z, Parke DN, Playa HC, Chen H, Miller DD, Seagroves TN, Li W.

Mol Cancer Ther. 2020 Feb;19(2):348-363. doi: 10.1158/1535-7163.MCT-19-0536. Epub 2019 Oct 23.

PMID:
31645441
4.

Endophthalmitis after Cataract Surgery in the United States: A Report from the Intelligent Research in Sight Registry, 2013-2017.

Pershing S, Lum F, Hsu S, Kelly S, Chiang MF, Rich WL 3rd, Parke DW 2nd.

Ophthalmology. 2020 Feb;127(2):151-158. doi: 10.1016/j.ophtha.2019.08.026. Epub 2019 Aug 28.

PMID:
31611015
5.

The Cell Therapy Buffet.

Parke DW 2nd.

Ophthalmology. 2019 Oct;126(10):1356-1357. doi: 10.1016/j.ophtha.2019.03.038. No abstract available.

PMID:
31543106
6.

Estimated number of ophthalmologists worldwide (International Council of Ophthalmology update): will we meet the needs?

Resnikoff S, Lansingh VC, Washburn L, Felch W, Gauthier TM, Taylor HR, Eckert K, Parke D, Wiedemann P.

Br J Ophthalmol. 2019 Jul 2. pii: bjophthalmol-2019-314336. doi: 10.1136/bjophthalmol-2019-314336. [Epub ahead of print]

7.

Continuing Professional Certification: Perspective of the American Academy of Ophthalmology.

Williams GA, Parke DW 2nd.

Ophthalmology. 2019 Jul;126(7):926-927. doi: 10.1016/j.ophtha.2019.03.043. Epub 2019 May 5. No abstract available.

PMID:
31068259
8.

Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.

Arnst KE, Wang Y, Lei ZN, Hwang DJ, Kumar G, Ma D, Parke DN, Chen Q, Yang J, White SW, Seagroves TN, Chen ZS, Miller DD, Li W.

Mol Pharmacol. 2019 Jul;96(1):73-89. doi: 10.1124/mol.118.114801. Epub 2019 May 1.

PMID:
31043459
9.

New Data Sets in Population Health Analytics.

Parke DW 2nd, Coleman AL.

JAMA Ophthalmol. 2019 Jun 1;137(6):640-641. doi: 10.1001/jamaophthalmol.2019.0410. No abstract available.

PMID:
30946434
10.

Characteristics and Outcomes of Full-thickness Macular Hole Repair in Patients Receiving Anti-VEGF Injections for Neovascular Age-related Macular Degeneration.

Ringeisen AL, Parke DW 3rd, Dev S.

Int Ophthalmol Clin. 2019 Winter;59(1):127-135. doi: 10.1097/IIO.0000000000000248. No abstract available.

PMID:
30585922
11.

Non-Lasered Drainage Retinotomies for Repair of Primary Rhegmatogenous Retinal Detachments.

Hodson TS, Isom RF, Parke DW 3rd.

Ophthalmic Surg Lasers Imaging Retina. 2018 Dec 1;49(12):955-960. doi: 10.3928/23258160-20181203-08.

PMID:
30566703
12.

Reconsidering the Postoperative Day 0 Visit for Retina Surgery.

Ringeisen AL, Parke DW 3rd.

Ophthalmic Surg Lasers Imaging Retina. 2018 Sep 1;49(9):e52-e56. doi: 10.3928/23258160-20180907-07.

PMID:
30222819
13.

PREDICTIVE FACTORS FOR PROLIFERATIVE VITREORETINOPATHY FORMATION AFTER UNCOMPLICATED PRIMARY RETINAL DETACHMENT REPAIR.

Xu K, Chin EK, Bennett SR, Williams DF, Ryan EH, Dev S, Mittra RA, Quiram PA, Davies JB, Parke DW 3rd, Boldt HC, Almeida DRP.

Retina. 2019 Aug;39(8):1488-1495. doi: 10.1097/IAE.0000000000002184.

PMID:
29787465
14.

Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.

Xu K, Chin EK, Bennett SR, Williams DF, Ryan EH, Dev S, Mittra RA, Quiram PA, Davies JB, Parke DW 3rd, Johnson JB, Cantrill HL, Almeida DRP.

Ophthalmology. 2018 Aug;125(8):1279-1286. doi: 10.1016/j.ophtha.2018.01.022. Epub 2018 Feb 21.

PMID:
29477689
15.

Return to the Operating Room after Macular Surgery: IRIS Registry Analysis.

Parke DW 3rd, Lum F.

Ophthalmology. 2018 Aug;125(8):1273-1278. doi: 10.1016/j.ophtha.2018.01.009. Epub 2018 Feb 14.

PMID:
29454658
16.

Performance Rates Measured in the American Academy of Ophthalmology IRIS© Registry (Intelligent Research in Sight).

Rich WL 3rd, Chiang MF, Lum F, Hancock R, Parke DW 2nd.

Ophthalmology. 2018 May;125(5):782-784. doi: 10.1016/j.ophtha.2017.11.033. Epub 2018 Jan 17. No abstract available.

PMID:
29342437
17.

The 2016 American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Database: Characteristics and Methods.

Chiang MF, Sommer A, Rich WL, Lum F, Parke DW 2nd.

Ophthalmology. 2018 Aug;125(8):1143-1148. doi: 10.1016/j.ophtha.2017.12.001. Epub 2018 Jan 17.

PMID:
29342435
18.

Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry.

Rao P, Lum F, Wood K, Salman C, Burugapalli B, Hall R, Singh S, Parke DW 2nd, Williams GA.

Ophthalmology. 2018 Apr;125(4):522-528. doi: 10.1016/j.ophtha.2017.10.010. Epub 2017 Nov 13.

PMID:
29146306
19.

The American Academy of Ophthalmology's IRIS® Registry (Intelligent Research in Sight Clinical Data): A Look Back and a Look to the Future.

Parke DW 2nd, Rich WL 3rd, Sommer A, Lum F.

Ophthalmology. 2017 Nov;124(11):1572-1574. doi: 10.1016/j.ophtha.2017.08.035. No abstract available.

PMID:
29055362
20.

In vivo study of Plasmodium falciparum chloroquine susceptibility in three departments of Haiti.

Raccurt CP, Brasseur P, Cicéron M, Parke DM, Zervos MJ, Boncy J.

Malar J. 2017 Aug 4;16(1):313. doi: 10.1186/s12936-017-1961-2.

21.

Preeclampsia and Long-term Risk of Maternal Retinal Disorders.

Coleman AL, Olsen TW, Lum F, Parke DW 2nd.

Obstet Gynecol. 2017 May;129(5):946-947. doi: 10.1097/AOG.0000000000002026. No abstract available.

PMID:
28426606
22.

Treatment Patterns for Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS Registry.

Willis J, Morse L, Vitale S, Parke DW 2nd, Rich WL, Lum F, Cantrell RA.

Ophthalmology. 2017 Jul;124(7):935-943. doi: 10.1016/j.ophtha.2017.02.018. Epub 2017 Mar 31.

PMID:
28372860
23.

Setting Sail: The Launch of Ophthalmology Retina.

Bartley GB, Parke DW.

Ophthalmol Retina. 2017 Jan - Feb;1(1):1. doi: 10.1016/j.oret.2016.09.011. Epub 2016 Nov 18. No abstract available.

PMID:
31047390
24.

Measuring and Mattering.

Parke DW 2nd.

Mo Med. 2016 Nov-Dec;113(6):448. No abstract available.

25.

Serologically Confirmed Zika-Related Unilateral Acute Maculopathy in an Adult.

Parke DW 3rd, Almeida DR, Albini TA, Ventura CV, Berrocal AM, Mittra RA.

Ophthalmology. 2016 Nov;123(11):2432-2433. doi: 10.1016/j.ophtha.2016.06.039. Epub 2016 Jul 27. No abstract available.

PMID:
27474145
26.

Pigmented Paravenous Retinochoroidal Atrophy.

Lenci LT, Parke DW 3rd, Almeida DR.

Ophthalmology. 2016 Oct;123(10):2112. doi: 10.1016/j.ophtha.2016.04.052. No abstract available.

PMID:
27664911
27.

Stem Cell Treatment: Think Twice If They Ask for Payment.

Parke DW 2nd, Lum F, McLeod SD.

Ophthalmology. 2016 Oct;123(10S):S62-S63. doi: 10.1016/j.ophtha.2016.07.039. No abstract available.

PMID:
27664287
28.
29.

Retinal Injury Secondary to Laser Pointers in Pediatric Patients.

Xu K, Chin EK, Quiram PA, Davies JB, Parke DW 3rd, Almeida DR.

Pediatrics. 2016 Oct;138(4). pii: e20161188. Epub 2016 Sep 1.

30.

Clinical Advantages of the 30×30-Degree Broad Scan in Spectral Domain Optical Coherence Tomography for Identifying Pathology.

Parke DW 3rd, Pulido CM, Ryan EH.

Int Ophthalmol Clin. 2016 Fall;56(4):119-25. doi: 10.1097/IIO.0000000000000137. No abstract available.

PMID:
27575763
31.

The American Academy of Ophthalmology and the Formation of the American Board of Ophthalmology.

Parke DW 2nd.

Ophthalmology. 2016 Sep;123(9 Suppl):S12-4. doi: 10.1016/j.ophtha.2016.06.009.

PMID:
27549995
32.

Integrating the Internship into Ophthalmology Residency Programs: Association of University Professors of Ophthalmology American Academy of Ophthalmology White Paper.

Oetting TA, Alfonso EC, Arnold A, Cantor LB, Carter K, Cruz OA, Feldon S, Mondino B, Parke DW 2nd, Pershing S, Uhler T, Volpe NJ.

Ophthalmology. 2016 Sep;123(9):2037-41. doi: 10.1016/j.ophtha.2016.06.021. Epub 2016 Jul 14.

PMID:
27423312
33.

The Prevalence of Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS(®) Data Registry and NHANES.

Willis JR, Vitale S, Morse L, Parke DW 2nd, Rich WL, Lum F, Cantrell RA.

Ophthalmology. 2016 Aug;123(8):1771-1782. doi: 10.1016/j.ophtha.2016.04.021. Epub 2016 Jun 21.

PMID:
27342789
34.

The Preferred Practice Pattern Guidelines in Ophthalmology.

Lum F, Feder RS, McLeod SD, Parke DW 2nd.

Ophthalmology. 2016 May;123(5):928-9. doi: 10.1016/j.ophtha.2016.01.024. No abstract available.

PMID:
27107351
35.

ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.

Brooks DL, Schwab LP, Krutilina R, Parke DN, Sethuraman A, Hoogewijs D, Schörg A, Gotwald L, Fan M, Wenger RH, Seagroves TN.

Mol Cancer. 2016 Mar 22;15:26. doi: 10.1186/s12943-016-0510-x.

36.

The US Preventive Services Task Force Recommendation on Vision Screening in Older Adults: A Narrow View.

Parke DW 2nd, Repka MX, Lum F.

JAMA Ophthalmol. 2016 May 1;134(5):485-486. doi: 10.1001/jamaophthalmol.2016.0222. No abstract available.

PMID:
26934146
37.

The SGR Fix: Was It?

Parke DW 2nd.

Mo Med. 2015 Nov-Dec;112(6):408-9. No abstract available.

38.

Unassisted Scleral Depression During Vitrectomy Surgery: Two Simple, Cost-Effective Techniques.

Mandelcorn ED, Manusow JS, Parke DW 3rd, Albini TA.

Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):577-8. doi: 10.3928/23258160-20150521-10.

PMID:
26057762
39.

Malaria elimination in Haiti by the year 2020: an achievable goal?

Boncy PJ, Adrien P, Lemoine JF, Existe A, Henry PJ, Raccurt C, Brasseur P, Fenelon N, Dame JB, Okech BA, Kaljee L, Baxa D, Prieur E, El Badry MA, Tagliamonte MS, Mulligan CJ, Carter TE, Beau de Rochars VM, Lutz C, Parke DM, Zervos MJ.

Malar J. 2015 Jun 5;14:237. doi: 10.1186/s12936-015-0753-9.

40.

Candida glabrata endophthalmitis transmitted from graft to host after descemet stripping automated endothelial keratoplasty.

Weng CY, Parke DW 3rd, Walter SD, Isom RF, Chang JS, Flynn HW Jr.

JAMA Ophthalmol. 2014 Nov;132(11):1381-3. doi: 10.1001/jamaophthalmol.2014.2780. No abstract available.

PMID:
25124791
41.

Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series.

Chen RW, Flynn HW Jr, Lee WH, Parke DW 3rd, Isom RF, Davis JL, Smiddy WE.

Am J Ophthalmol. 2014 Apr;157(4):870-875.e1. doi: 10.1016/j.ajo.2013.12.019. Epub 2013 Dec 31.

42.

Management of suprachoroidal 5,000-centistoke silicone oil: two contrasting approaches.

Chang JS, Parke DW 3rd, Flynn HW Jr, Pathengay A, Albini T.

Ophthalmic Surg Lasers Imaging Retina. 2013 Nov 1;44(6):610-2. doi: 10.3928/23258160-20131022-02. Epub 2013 Oct 30.

PMID:
24170121
43.

Choosing Wisely: five ideas that physicians and patients can discuss.

Parke DW 2nd, Coleman AL, Rich WL 3rd, Lum F.

Ophthalmology. 2013 Mar;120(3):443-444. doi: 10.1016/j.ophtha.2013.01.017. No abstract available.

PMID:
23714602
44.

Management of intraocular foreign bodies: a clinical flight plan.

Parke DW 3rd, Flynn HW Jr, Fisher YL.

Can J Ophthalmol. 2013 Feb;48(1):8-12. doi: 10.1016/j.jcjo.2012.11.005. Review.

PMID:
23419293
45.

Use of fluorescein angiography in incontinentia pigmenti: a case report.

Tzu JH, Murdock J, Parke DW 3rd, Warman R, Hess DJ, Berrocal AM.

Ophthalmic Surg Lasers Imaging Retina. 2013 Jan-Feb;44(1):91-3. doi: 10.3928/23258160-20121221-20.

PMID:
23410815
46.

Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification.

Parke DW 3rd, Sisk RA, Murray TG.

Clin Ophthalmol. 2012;6:1347-53. doi: 10.2147/OPTH.S34653. Epub 2012 Aug 17.

47.

Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification.

Parke DW 3rd, Sisk RA, Houston SK, Murray TG.

Clin Ophthalmol. 2012;6:925-31. doi: 10.2147/OPTH.S32934. Epub 2012 Jun 18.

48.

Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies.

Parke DW 3rd, Pathengay A, Flynn HW Jr, Albini T, Schwartz SG.

J Ophthalmol. 2012;2012:758526. doi: 10.1155/2012/758526. Epub 2012 Apr 26.

49.

Preclinical characterization of a novel diphenyl benzamide selective ERα agonist for hormone therapy in prostate cancer.

Coss CC, Jones A, Parke DN, Narayanan R, Barrett CM, Kearbey JD, Veverka KA, Miller DD, Morton RA, Steiner MS, Dalton JT.

Endocrinology. 2012 Mar;153(3):1070-81. doi: 10.1210/en.2011-1608. Epub 2012 Jan 31.

PMID:
22294742
50.

Managing conflict of interest: the academy's preferred practice patterns and ophthalmic technology assessments.

Parke DW 2nd, Coleman AL, Lum F.

Ophthalmology. 2011 Aug;118(8):1493-4. doi: 10.1016/j.ophtha.2011.05.002. No abstract available.

PMID:
21813089

Supplemental Content

Support Center